Community Liver Alliance Annual Liver Cancer Conference

September 26, 2020

The goal of this course module is to help clinicians and other service providers understand the management of Hepatocellular Carcinoma in the US population, innovations in therapies and advances in research and development.

Target Audience

This program is directed to providers, patients and caregivers. Concurrent educational sessions will be held for hepatologists, gastroenterologists, oncologists, primary care physicians and other health care providers involved in the management of patients with liver cancer. A separate session will be geared towards patients and their caregivers.

Learning Objectives

At course completion, attendees should be able to:

Increase Knowledge

• Understand the molecular classification of HCC

• Understand the multidisciplinary approach to management of HCC

Competency

• Define the mechanisms that lead to the development of hepatocellular cancer (HCC)

Performance

• Discuss the available evidence-based data on promising treatment options for advanced HCC

• Discuss the advances in research and development

Course summary
Available credit: 
  • 5.50 AAPA Category I CME
  • 5.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 5.50 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 5.50 Attendance
Course opens: 
09/26/2020
Course expires: 
12/31/2020
Event starts: 
09/26/2020 - 8:00am
Event ends: 
09/26/2020 - 6:00pm

Schedule

7:30 a.m. Registration & Breakfast

8:00 a.m. Welcome and Overview, Dulabh Monga, MD

8:10 a.m. Keynote Speaker

HCC: The State of Art in Pathogenesis and Diagnosis Augusto Villanueva, MD, PhD

Liver Cancer Program - Tisch Cancer Institute

Divisions of Liver Diseases / Hematology and Medical Oncology - Department of Medicine

Icahn School of Medicine at Mount Sinai

New York, NY

9:00 a.m. Risk factors for HCC, and HCC surveillance Jaideep Behari, MD, PhD

Transplant Hepatology

UPMC Center for Liver Diseases

Pittsburgh, PA

UPMC Center for Liver Diseases

9:30 a.m. Role of Surgical Resection and Transplantation in HCC Management David Geller, MD

Director, UPMC Liver Cancer Center

Pittsburgh, PA

10:00 a.m. Role of Locoregional Therapies in HCC Management Andrew Klobuka, MD

Department of Radiology

Allegheny Health Network

Pittsburgh, PA

10:30 a.m. Medical Management of HCC

Dulabh K. Monga, MD

Program Director

Hematology Oncology Fellowship

Assistant Professor of Medicine

Temple University School of Medicine

Allegheny Health Network

Pittsburgh, PA

11:00 a.m. Break

11:30 a.m. Radiation Therapy for HCC

Alexander Kirichenko, MD

System Director, SRS/SRT Programs

Allegheny Health Network

Pittsburgh, PA

12:00 p.m. Lunch and Advocacy Update

Suzanna Masartis

Executive Director

Community Liver Alliance

Pittsburgh, PA

1:00 p.m. Precision Medical Oncology in HCC: How can we begin? Satdarshan (Paul) Monga, MD

Pittsburgh Liver Research Center,

University of Pittsburgh, School of 4

Medicine and UPMC

Pittsburgh, PA

1:30 p.m. State of the Art in Intrahepatic Cholangiocarcinoma: Diagnosis and Treatment Mitesh Borad, MD

Associate Professor of Medicine

Consultant, Division of Hematology/Oncology, Department of Internal Medicine

Consultant, Department of Molecular Medicine

Mayo Clinic

Scottsdale, AZ

2:00 p.m. Case presentations

Resectable/transplantable HCC

Akshata Moghe, MD

Chief GI/Hepatology Fellow

UPMC Starzl Transplant Services

Pittsburgh, PA

Non-Resectable Non-transplantable HCC and Medical and Locoregional Options Srividya Srinivasamaharaj, MD

Hepatology Oncology Fellow

Allegheny Health Network

Pittsburgh, PA

Intrahepatic Cholangiocarcinoma

Srividya Srinivasamaharaj, MD

Hepatology Oncology Fellow

Allegheny Health Network

Pittsburgh, PA

2:30 p.m. Adjourn

Live Virtual Program
Pittsburgh
United States

 

Course Directors

Dulabh Kaur Monga, MD

Medical Oncologist

Program Director, Hematology Oncology Fellowship

Assistant Professor of Medicine

Temple University School of Medicine

Allegheny Health Network

Pittsburgh, PA

Satdarshan (Paul) Singh Monga, MD

UPMC Endowed Chair for Experimental Pathology

Professor of Pathology and Medicine

Director, Pittsburgh Liver Research Center,

Chief and Vice Chair, Division of Experimental Pathology

University of Pittsburgh, School of Medicine and UPMC

Pittsburgh, PA

Faculty Listing

David Geller, MD

Richard L. Simmons Professor of Surgery

Chief, Division of Hepatobiliary and Pancreatic Surgery

Director, UPMC Liver Cancer Center

Pittsburgh, PA

Andrew Klobuka, MD

Interventional Radiologist

Department of Radiology

Allegheny Health Network

Pittsburgh, PA

Alexander Kirichenko, MD

Radiation Oncologist

System Director, SRS/SRT Programs

Allegheny Health Network

Pittsburgh, PA

Dulabh K. Monga, MD

Medical Oncologist

AGH Medical Oncology

Allegheny Health Network

Pittsburgh, PA

Paul Monga, MD

UPMC Endowed Professor for Experimental Pathology

Director, Pittsburgh Liver Research Center

University of Pittsburgh, School of Medicine and UPMC

Pittsburgh, PA

Jaideep Behari, MD, PhD

Hepatologist

Associate Professor of Medicine

Co-Director, Liver Translational Research Program

UPMC Center for Liver Diseases

Pittsburgh, PA

Augusto Villanueva, MD, PhD

Hepatologist

Liver Cancer Program - Tisch Cancer Institute

Divisions of Liver Diseases/Hematology and Medical Oncology

Icahn School of Medicine at Mount Sinai

New York, NY

Mitesh Borad, MD

Medical Oncologist

Associate Professor of Medicine

Division of Hematology/Oncology, Internal Medicine & Department of Molecular Medicine

Mayo Clinic

Scottsdale, AZ

Akshata Moghe, MD

Chief GI/Hepatology Fellow

UPMC Starzl Transplant Services

Pittsburgh, PA

Srividya Srinivasamaharaj, MD

Hepatology Oncology Fellow

Allegheny Health Network

Pittsburgh, PA

Suzanna Masartis,

Executive Director

Community Liver Alliance

Pittsburgh, PA

Continuing Education Credit
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Community Liver Alliance. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.5 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 5.50 AAPA Category I CME
  • 5.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 5.50 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 5.50 Attendance
Please login or register to take this course.